近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
Establishing the importance of oil-membrane interactions on the transmembrane diffusion of physicochemically diverse compoundsNajib, O. N., Martin, G. P., Kirton, S., Sallam, A-S. & Murnane, D. 15 Jun 2016 In : International Journal of Pharmaceutics. 506, 1-2, p. 429 437 p.Article
Interaction of Formulation and Device Factors Determine the In Vitro Performance of Salbutamol Sulphate Dry Powders for InhalationMuddle, J., Murnane, D., Parisini, I., Brown, M., Page, C. & Forbes, B. Nov 2015 In : International journal of pharmaceutical compounding. 104, 11, p. 3861-9 9 p.Article
Formulation pre-screening of inhalation powders using computational atom-atom systematic search methodRamachandran, V., Murnane, D., Hammond, R. B., Pickering, J., Roberts, K. J., Soufian, M., Forbes, B., Jaffari, S., Martin, G. P., Collins, E. & Pencheva, K. 5 Jan 2015 In : Molecular Pharmaceutics. 12, 1, p. 18-33 16 p.Article
Direct Ionization of Solid-Phase Microextraction Fibers for Quantitative Drug Bionalysis: From Peripheral Circulation to Mass Spectrometry DetectionSheelan, A., Michael, T., Neil, S., Murnane, D. & Gerhard, U. 2015 In : Analytical Chemistry. 87, 1, p. 754-759Article
Evidence for the existence of powder sub-populations in micronized materials: Aerodynamic size-fractions of aerosolized powders possess distinct physicochemical propertiesJaffari, S., Forbes, B., Collins, E., Khoo, J., Martin, G. P. & Murnane, D. Dec 2014 In : Pharmaceutical Research. 31, 12, p. 3251-3264Article
Potential of a cyclone prototype spacer to improve in vitro dry powder deliveryParisini, I., Cheng, S. J., Symons, D. & Murnane, D. May 2014 In : Pharmaceutical Research. 31, 5, p. 1133-1145Article
Dynamics of aerosol size during inhalation: Hygroscopic growth of commercial nebulizer formulationsHaddrell, A. E., Davies, J. F., Miles, R. E. H., Reid, J. P., Dailey, L. A. & Murnane, D. 10 Mar 2014 In : International Journal of Pharmaceutics. 463, 1, p. 50-61 12 p.Article
Assessment of a cyclone-type spacer device for use in dry powder inhalationParisini, I., Cheng, S. J., Symons, D. D., Brown, M., Kostrzewski, A. & Murnane, D. Aug 2013 In : Journal of Aerosol Medicine and Pulmonary Drug Delivery. 26, 4, p. A5 1 p., 11Meeting abstract
The effect of aerodynamic particle size and solid state disorder on salmeterol xinafoate deposition from pressurised metered dose and dry powder inhaler formulationsJaffari, S., Sandhu, G., Martin, G. P., Forbes, B., Collins, E. & Murnane, D. Aug 2013 In : Journal of Aerosol Medicine and Pulmonary Drug Delivery. 26, 4, p. A237 1 p.Meeting abstract
Rapid characterisation of the inherent dispersibility of respirable powders using dry dispersion laser diffractionJaffari, S., Forbes, B., Collins, E., Barlow, D. J., Martin, G. P. & Murnane, D. Apr 2013 In : International Journal of Pharmaceutics. 447, 1-2, p. 124-131Article
Nitrogen-14 Nuclear Quadrupole Resonance Spectroscopy: a powerful new analytical methodology for medicines authentication and counterfeit antimalarial analysisBarras, J., Murnane, D., Althoefer, K., Assi, S., Rowe, M. I. D., Poplett, I. J. F., Kyriakidou, G. & Smith, J. A. S. 5 Feb 2013 In : Analytical Chemistry. 85, 5, p. 2746-2753Article
Concordance, adherence or competence – device use and therapeutic outcomes in older patientsMurnane, D. 2013 In : Regulatory Rapporteur. 10, 7, p. 10-11Article
Formation and measurement of process induced disorder during the manufacture of inhalation medicinesRoyall, P. G., Woodhead, B., Tang, S. J., Martin, G. P., Stockton, B. M. & Murnane, D. 1 Jul 2011 In : Journal of Drug Delivery Science and Technology. 21, 4, p. 311-318 8 p.Article
Characterization of latent heat-releasing phase change materials for dermal therapiesWood, D. G., Brown, M., Jones, S. A. & Murnane, D. 28 Apr 2011 In : Journal of Physical Chemistry C. 115, 16, p. 8369-8375 7 p.Article
Transiently supersaturated solutions from the dissolution of amorphous powders for topical drug deliveryPalmer, I. A., Jones, S. A., Murnane, D., Traynor, M. J., Moss, G. & Brown, M. Jun 2010 In : Journal of Pharmacy and Pharmacology. 62, 6, p. 795 1 p.Meeting abstract
Dry Powder Formulations for Inhalation of Fluticasone Propionate and Salmeterol Xinafoate MicrocrystalsMurnane, D., Martin, G. P. & Marriott, C. Feb 2009 In : Journal of Pharmaceutical Sciences. 98, 2, p. 503-515 13 p.Article
Investigations into the formulation of metered dose inhalers of salmeterol xinafoate and fluticasone propionate microcrystalsMurnane, D., Martin, G. P. & Marriott, C. Oct 2008 In : Pharmaceutical Research. 25, 10, p. 2283-2291 9 p.Article
Polymorphic control of inhalation microparticles prepared by crystallizationMurnane, D., Marriott, C. & Martin, G. P. 1 Sep 2008 In : International Journal of Pharmaceutics. 361, 1-2, p. 141-149 9 p.Article
In situ and Ex situ analysis of salmeterol xinafoate microcrystal formation from poly(ethylene glycol) 400 - Water cosolvent mixturesMurnane, D., Marriott, C. & Martin, G. P. Jun 2008 In : Crystal Growth & Design. 8, 6, p. 1855-1862 8 p.Article
Comparison of salmeterol xinafoate microparticle production by conventional and novel antisolvent crystallizationMurnane, D., Marriott, C. & Martin, G. P. May 2008 In : European Journal of Pharmaceutics and Biopharmaceutics. 69, 1, p. 94-105 12 p.Article